ESPE Abstracts (2016) 86 P-P2-301

aDepartment of Pediatric Endocrinology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran; bSchool of Medicine, Islamic Azad University of Najafabad, Isfahan, Iran; cDepartment of Pediatric, Islamic Azad University of Najafabad, Isfahan, Iran; dDepartment of Pediatric, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran


Background: Diabetes mellitus type 1 (T1DM) is the most common chronic diseases in children. Studies show that the prevalence of vitamin D deficiency is higher in this group of patients.

Objective and hypotheses: The aim of this study was evaluation HbA1C and IGF-1 levels in children with T1DM that receiving vitamin D supplement.

Method: A total of 30 diabetic children 5–15 years with 25(OH) D levels lower than 74 nmol/l (29 ng/ml) were selected. Vitamin D supplement were given to patients for 8 weeks. Concentrations of serum 25(OH) D, IGF-1 and HbA1c were compared between baseline and after treatment.

Results: The mean concentrations of serum 25(OH) D and IGF-I were significantly increased from 16.27±6.56 and 245.57±108.9 at baseline to 40.80±1.17 and 264.46±104.30 respectively. The mean concentrations of HbA1c were significantly decreased from 8.89±1.39 to 8.60±1.23 (P=0.047). Serum HbA1c correlated negatively with Serum 25(OH)D (r=−0.40, P=0.05) and IGF1 (r=−0.69, P<0.001).

Conclusion: Treatment with vitamin D improved glycemic control in children with T1DM. This study showed that serum IGF1 related to glucose homeostasis in this patients.

Volume 86

55th Annual ESPE (ESPE 2016)

Paris, France
10 Sep 2016 - 12 Sep 2016

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

Authors